Prioritising at-risk adults in vaccine coadministration trials

^*Corresponding author af dette arbejde

Originalsprog	Engelsk
Tidsskrift	The Lancet Infectious Diseases
Vol/bind	25
Udgave nummer	4
Sider (fra-til)	362-363
Antal sider	2
ISSN	1473-3099
DOI	https://doi.org/10.1016/S1473-3099(24)00674-1
Status	Udgivet - apr. 2025

Adgang til dokumentet

@article{82daa091108540e58e4577d7ae6a1829,

title = "Prioritising at-risk adults in vaccine coadministration trials",

author = "{Barrella Harboe}, Zitta and Omid Rezahosseini and Eberhardt, {Christiane S}",

year = "2025",

month = apr,

doi = "10.1016/S1473-3099(24)00674-1",

language = "English",

volume = "25",

pages = "362--363",

journal = "The Lancet Infectious Diseases",

issn = "1473-3099",

publisher = "Elsevier Limited",

number = "4",

}

TY - JOUR

T1 - Prioritising at-risk adults in vaccine coadministration trials

AU - Barrella Harboe, Zitta

AU - Rezahosseini, Omid

AU - Eberhardt, Christiane S

PY - 2025/4

Y1 - 2025/4

UR - http://www.scopus.com/inward/record.url?scp=85212657767&partnerID=8YFLogxK

U2 - 10.1016/S1473-3099(24)00674-1

DO - 10.1016/S1473-3099(24)00674-1

M3 - Comment/debate

C2 - 39608387

SN - 1473-3099

VL - 25

SP - 362

EP - 363

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

IS - 4

ER -